-
1
المؤلفون: K. I. Polyakova, A. G. Fisun, A. V. Govorov, V. S. Krysanova, D. A. Andreev, T. N. Ermolaeva, I. I. Andreyashkina, A. A. Zavyalov, M. V. Davydovskaya, K. A. Kokushkin
المصدر: Onkourologiâ, Vol 15, Iss 2, Pp 77-85 (2019)
مصطلحات موضوعية: medicine.medical_specialty, Urology, Population, 030232 urology & nephrology, costs, pharmacoeconomic analysis, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Enzalutamide, castration-resistant prostate cancer, Radiology, Nuclear Medicine and imaging, Medical prescription, education, education.field_of_study, business.industry, Goserelin, medicine.disease, prostate cancer, Oncology, chemistry, Nephrology, Cabazitaxel, 030220 oncology & carcinogenesis, Hormonal therapy, high-cost therapy, Medicine, Surgery, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a09f25b55ddeeaa24d8f8e808ec3dda3
https://oncourology.abvpress.ru/oncur/article/view/921